IBDEI07W ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7822,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7822,1,3,0)
 ;;=3^Inflammatory Disease of Prostate,Unspec
 ;;^UTILITY(U,$J,358.3,7822,1,4,0)
 ;;=4^N41.9
 ;;^UTILITY(U,$J,358.3,7822,2)
 ;;=^5015694
 ;;^UTILITY(U,$J,358.3,7823,0)
 ;;=N70.91^^42^500^79
 ;;^UTILITY(U,$J,358.3,7823,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7823,1,3,0)
 ;;=3^Salpingitis,Unspec
 ;;^UTILITY(U,$J,358.3,7823,1,4,0)
 ;;=4^N70.91
 ;;^UTILITY(U,$J,358.3,7823,2)
 ;;=^5015806
 ;;^UTILITY(U,$J,358.3,7824,0)
 ;;=N70.93^^42^500^78
 ;;^UTILITY(U,$J,358.3,7824,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7824,1,3,0)
 ;;=3^Salpingitis & Oophoritis,Unspec
 ;;^UTILITY(U,$J,358.3,7824,1,4,0)
 ;;=4^N70.93
 ;;^UTILITY(U,$J,358.3,7824,2)
 ;;=^5015808
 ;;^UTILITY(U,$J,358.3,7825,0)
 ;;=N70.92^^42^500^56
 ;;^UTILITY(U,$J,358.3,7825,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7825,1,3,0)
 ;;=3^Oophoritis,Unspec
 ;;^UTILITY(U,$J,358.3,7825,1,4,0)
 ;;=4^N70.92
 ;;^UTILITY(U,$J,358.3,7825,2)
 ;;=^5015807
 ;;^UTILITY(U,$J,358.3,7826,0)
 ;;=N73.9^^42^500^38
 ;;^UTILITY(U,$J,358.3,7826,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7826,1,3,0)
 ;;=3^Inflammatory Disease Female Pelvic,Unspec
 ;;^UTILITY(U,$J,358.3,7826,1,4,0)
 ;;=4^N73.9
 ;;^UTILITY(U,$J,358.3,7826,2)
 ;;=^5015820
 ;;^UTILITY(U,$J,358.3,7827,0)
 ;;=A56.11^^42^500^37
 ;;^UTILITY(U,$J,358.3,7827,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7827,1,3,0)
 ;;=3^Inflammatory Disease Chlamydial Female Pelvic
 ;;^UTILITY(U,$J,358.3,7827,1,4,0)
 ;;=4^A56.11
 ;;^UTILITY(U,$J,358.3,7827,2)
 ;;=^5000342
 ;;^UTILITY(U,$J,358.3,7828,0)
 ;;=N73.5^^42^500^65
 ;;^UTILITY(U,$J,358.3,7828,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7828,1,3,0)
 ;;=3^Peritonitis Female Pelvic,Unspec
 ;;^UTILITY(U,$J,358.3,7828,1,4,0)
 ;;=4^N73.5
 ;;^UTILITY(U,$J,358.3,7828,2)
 ;;=^5015817
 ;;^UTILITY(U,$J,358.3,7829,0)
 ;;=N72.^^42^500^36
 ;;^UTILITY(U,$J,358.3,7829,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7829,1,3,0)
 ;;=3^Inflammatory Disease Cervix Uteri
 ;;^UTILITY(U,$J,358.3,7829,1,4,0)
 ;;=4^N72.
 ;;^UTILITY(U,$J,358.3,7829,2)
 ;;=^5015812
 ;;^UTILITY(U,$J,358.3,7830,0)
 ;;=N76.3^^42^500^96
 ;;^UTILITY(U,$J,358.3,7830,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7830,1,3,0)
 ;;=3^Vulvitis,Subacute & Chronic
 ;;^UTILITY(U,$J,358.3,7830,1,4,0)
 ;;=4^N76.3
 ;;^UTILITY(U,$J,358.3,7830,2)
 ;;=^5015829
 ;;^UTILITY(U,$J,358.3,7831,0)
 ;;=N76.1^^42^500^92
 ;;^UTILITY(U,$J,358.3,7831,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7831,1,3,0)
 ;;=3^Vaginitis,Subacute & Chronic
 ;;^UTILITY(U,$J,358.3,7831,1,4,0)
 ;;=4^N76.1
 ;;^UTILITY(U,$J,358.3,7831,2)
 ;;=^5015827
 ;;^UTILITY(U,$J,358.3,7832,0)
 ;;=N76.2^^42^500^95
 ;;^UTILITY(U,$J,358.3,7832,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7832,1,3,0)
 ;;=3^Vulvitis,Acute
 ;;^UTILITY(U,$J,358.3,7832,1,4,0)
 ;;=4^N76.2
 ;;^UTILITY(U,$J,358.3,7832,2)
 ;;=^5015828
 ;;^UTILITY(U,$J,358.3,7833,0)
 ;;=N76.0^^42^500^91
 ;;^UTILITY(U,$J,358.3,7833,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7833,1,3,0)
 ;;=3^Vaginitis,Acute
 ;;^UTILITY(U,$J,358.3,7833,1,4,0)
 ;;=4^N76.0
 ;;^UTILITY(U,$J,358.3,7833,2)
 ;;=^5015826
 ;;^UTILITY(U,$J,358.3,7834,0)
 ;;=M00.20^^42^500^4
 ;;^UTILITY(U,$J,358.3,7834,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7834,1,3,0)
 ;;=3^Arthritis Streptococcal,Unspec Joint
 ;;^UTILITY(U,$J,358.3,7834,1,4,0)
 ;;=4^M00.20
 ;;^UTILITY(U,$J,358.3,7834,2)
 ;;=^5009645
 ;;^UTILITY(U,$J,358.3,7835,0)
 ;;=M00.80^^42^500^5
 ;;^UTILITY(U,$J,358.3,7835,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7835,1,3,0)
 ;;=3^Arthritis d/t Bacteria,Unspec Joint
 ;;^UTILITY(U,$J,358.3,7835,1,4,0)
 ;;=4^M00.80
 ;;^UTILITY(U,$J,358.3,7835,2)
 ;;=^5009669
 ;;^UTILITY(U,$J,358.3,7836,0)
 ;;=M00.9^^42^500^76
 ;;^UTILITY(U,$J,358.3,7836,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7836,1,3,0)
 ;;=3^Pyogenic Arthritis,Unspec
 ;;^UTILITY(U,$J,358.3,7836,1,4,0)
 ;;=4^M00.9
 ;;^UTILITY(U,$J,358.3,7836,2)
 ;;=^5009693
 ;;^UTILITY(U,$J,358.3,7837,0)
 ;;=M00.00^^42^500^82
 ;;^UTILITY(U,$J,358.3,7837,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7837,1,3,0)
 ;;=3^Staphylococcal Arthritis,Unspec Joint
 ;;^UTILITY(U,$J,358.3,7837,1,4,0)
 ;;=4^M00.00
 ;;^UTILITY(U,$J,358.3,7837,2)
 ;;=^5009597
 ;;^UTILITY(U,$J,358.3,7838,0)
 ;;=M00.10^^42^500^69
 ;;^UTILITY(U,$J,358.3,7838,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7838,1,3,0)
 ;;=3^Pneumococcal Arthritis,Unspec Joint
 ;;^UTILITY(U,$J,358.3,7838,1,4,0)
 ;;=4^M00.10
 ;;^UTILITY(U,$J,358.3,7838,2)
 ;;=^5009621
 ;;^UTILITY(U,$J,358.3,7839,0)
 ;;=M86.20^^42^500^63
 ;;^UTILITY(U,$J,358.3,7839,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7839,1,3,0)
 ;;=3^Osteomyelitis,Subacute,Unspec Site
 ;;^UTILITY(U,$J,358.3,7839,1,4,0)
 ;;=4^M86.20
 ;;^UTILITY(U,$J,358.3,7839,2)
 ;;=^5014535
 ;;^UTILITY(U,$J,358.3,7840,0)
 ;;=M86.10^^42^500^59
 ;;^UTILITY(U,$J,358.3,7840,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7840,1,3,0)
 ;;=3^Osteomyelitis,Acute,Unspec Site
 ;;^UTILITY(U,$J,358.3,7840,1,4,0)
 ;;=4^M86.10
 ;;^UTILITY(U,$J,358.3,7840,2)
 ;;=^5014521
 ;;^UTILITY(U,$J,358.3,7841,0)
 ;;=M86.00^^42^500^58
 ;;^UTILITY(U,$J,358.3,7841,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7841,1,3,0)
 ;;=3^Osteomyelitis,Acute Hematogenous,Unspec Site
 ;;^UTILITY(U,$J,358.3,7841,1,4,0)
 ;;=4^M86.00
 ;;^UTILITY(U,$J,358.3,7841,2)
 ;;=^5014497
 ;;^UTILITY(U,$J,358.3,7842,0)
 ;;=M86.50^^42^500^60
 ;;^UTILITY(U,$J,358.3,7842,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7842,1,3,0)
 ;;=3^Osteomyelitis,Chronic Hematogenous,Unspec Site
 ;;^UTILITY(U,$J,358.3,7842,1,4,0)
 ;;=4^M86.50
 ;;^UTILITY(U,$J,358.3,7842,2)
 ;;=^5014607
 ;;^UTILITY(U,$J,358.3,7843,0)
 ;;=M86.30^^42^500^61
 ;;^UTILITY(U,$J,358.3,7843,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7843,1,3,0)
 ;;=3^Osteomyelitis,Chronic Multifocal,Unspec Site
 ;;^UTILITY(U,$J,358.3,7843,1,4,0)
 ;;=4^M86.30
 ;;^UTILITY(U,$J,358.3,7843,2)
 ;;=^5014559
 ;;^UTILITY(U,$J,358.3,7844,0)
 ;;=M86.8X9^^42^500^64
 ;;^UTILITY(U,$J,358.3,7844,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7844,1,3,0)
 ;;=3^Osteomyelitis,Unspec Sites
 ;;^UTILITY(U,$J,358.3,7844,1,4,0)
 ;;=4^M86.8X9
 ;;^UTILITY(U,$J,358.3,7844,2)
 ;;=^5014655
 ;;^UTILITY(U,$J,358.3,7845,0)
 ;;=M86.60^^42^500^62
 ;;^UTILITY(U,$J,358.3,7845,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7845,1,3,0)
 ;;=3^Osteomyelitis,Chronic,Unspec Site
 ;;^UTILITY(U,$J,358.3,7845,1,4,0)
 ;;=4^M86.60
 ;;^UTILITY(U,$J,358.3,7845,2)
 ;;=^5014630
 ;;^UTILITY(U,$J,358.3,7846,0)
 ;;=M86.40^^42^500^57
 ;;^UTILITY(U,$J,358.3,7846,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7846,1,3,0)
 ;;=3^Osteomyelitis w/ Draining Sinus,Chronic,Unspec Site
 ;;^UTILITY(U,$J,358.3,7846,1,4,0)
 ;;=4^M86.40
 ;;^UTILITY(U,$J,358.3,7846,2)
 ;;=^5014583
 ;;^UTILITY(U,$J,358.3,7847,0)
 ;;=R50.2^^42^500^24
 ;;^UTILITY(U,$J,358.3,7847,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7847,1,3,0)
 ;;=3^Fever,Drug-Induced
 ;;^UTILITY(U,$J,358.3,7847,1,4,0)
 ;;=4^R50.2
 ;;^UTILITY(U,$J,358.3,7847,2)
 ;;=^5019507
 ;;^UTILITY(U,$J,358.3,7848,0)
 ;;=R50.9^^42^500^28
 ;;^UTILITY(U,$J,358.3,7848,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7848,1,3,0)
 ;;=3^Fever,Unspec
 ;;^UTILITY(U,$J,358.3,7848,1,4,0)
 ;;=4^R50.9
 ;;^UTILITY(U,$J,358.3,7848,2)
 ;;=^5019512
 ;;^UTILITY(U,$J,358.3,7849,0)
 ;;=R76.11^^42^500^1
 ;;^UTILITY(U,$J,358.3,7849,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7849,1,3,0)
 ;;=3^Abnormal Reaction to TB Test w/o Active TB
 ;;^UTILITY(U,$J,358.3,7849,1,4,0)
 ;;=4^R76.11
 ;;^UTILITY(U,$J,358.3,7849,2)
 ;;=^5019570
 ;;^UTILITY(U,$J,358.3,7850,0)
 ;;=Z21.^^42^500^31
 ;;^UTILITY(U,$J,358.3,7850,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7850,1,3,0)
 ;;=3^HIV Asymptomatic,Infection Status
 ;;^UTILITY(U,$J,358.3,7850,1,4,0)
 ;;=4^Z21.
 ;;^UTILITY(U,$J,358.3,7850,2)
 ;;=^5062777
